Bio-Rad and Caliper plan miniature laboratory products:
This article was originally published in Clinica
Bio-Rad Laboratories and Caliper Technologies are to develop and market a new microfluidics system. The deal centres on Mountain View, California-based Caliper's LabChip technology, which miniaturises and accelerates tests which can require large pieces of laboratory equipment, automating and integrating them into a chip-based process. Bio-Rad, of Hercules, California, will provide R&D funding, as well as acting as exclusive manufacturer of the devices, and will pay royalties on sales of software and instruments. The deal gives Caliper access to Bio-Rad's 70,000 clinical diagnostics and life science research customers.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.